Search by Drug Name or NDC

    NDC 24275-0185-01 Fludeoxyglucose F18 300 mCi/mL Details

    Fludeoxyglucose F18 300 mCi/mL

    Fludeoxyglucose F18 is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCSF Radiopharmaceutical Facility. The primary component is FLUDEOXYGLUCOSE F-18.

    Product Information

    NDC 24275-0185
    Product ID 24275-0185_09abfc29-c5d8-74fe-e063-6394a90a5adb
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Fludeoxyglucose F18
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fludeoxyglucose F18
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 300
    Active Ingredient Units mCi/mL
    Substance Name FLUDEOXYGLUCOSE F-18
    Labeler Name UCSF Radiopharmaceutical Facility
    Pharmaceutical Class Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203902
    Listing Certified Through 2024-12-31

    Package

    NDC 24275-0185-01 (24275018501)

    NDC Package Code 24275-0185-1
    Billing NDC 24275018501
    Package 17 mL in 1 VIAL, GLASS (24275-0185-1)
    Marketing Start Date 2013-01-02
    NDC Exclude Flag N
    Pricing Information N/A
    << 24208-0965-01 24275-0385-01 >>

    Contents